{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

AINewsBreaks – Beeline Holdings Inc. (NASDAQ: BLNE) Scales Digital Lending Capabilities with New Self-Service Feature

April 29, 2026Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform, has debuted a new automated lending pathway designed to streamline the home financing process. “The company recently introduced its Self-Service Mortgage Experience (‘SSME’), a platform feature that allows borrowers to explore customized loan options, model mortgage scenarios and lock interest rates entirely online.


BioMedNewsBreaks — Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 1 Data and Plans Phase 2 Study for Lyme Disease Prevention Candidate

April 29, 2026Tonix Pharmaceuticals (NASDAQ: TNXP) announced the presentation of Phase 1 data and plans for an adaptive Phase 2 field study of TNX-4800, a long-acting monoclonal antibody for the prevention of Lyme disease, with initiation expected in the first half of 2027 pending FDA agreement. The candidate, licensed from UMass Chan Medical School, targets Borrelia burgdorferi and is designed to provide extended protection during tick season, with the company highlighting its potential advantages over traditional vaccine approaches and noting the absence of currently approved prophylactic options in the United States.


American Fusion(TM) Inc. (AMFN) Targets Government and Defense Channels to Accelerate Commercialization

April 29, 2026 American Fusion(TM) has appointed a government procurement advisor to expand access to non-dilutive funding channels, prioritizing defense, DOE, and international programs as early commercialization pathways. The company’s Texatron(TM) platform is being positioned for modular, infrastructure-grade applications, with government alignment reflecting a wider trend in fusion toward staged, program-based development.


MissionIRNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Expands predictBBB Platform Into Large Quantitative Model for Drug Discovery

April 29, 2026Lantern Pharma (NASDAQ: LTRN) announced the expansion of its predictBBB(TM) platform into a Large Quantitative Model (LQM), delivering a real-time, web-based molecular intelligence engine that enables researchers to generate comprehensive developability profiles for small molecules from a single SMILES input. The enhanced platform leverages Lantern’s RADR(R) AI technology to provide rapid, high-dimensional analysis across physicochemical properties, drug-likeness, structural architecture and topological mapping, with benchmark-validated performance and accessibility designed to streamline drug discovery workflows and broaden access to advanced computational tools.


Web3MediaBreaks – NextPlat Corp (NASDAQ: NXPL, NXPLW) Highlights Turnaround Progress With Margin Expansion and Path to Profitability

April 29, 2026NextPlat (NASDAQ: NXPL, NXPLW) announced continued progress in its turnaround strategy, citing expected lower operating expenses, improved margins and sequential performance gains in Q1 2026 driven by higher-margin contracted healthcare services. The company anticipates gross margins exceeding 34% and operating expense reductions of approximately 9% quarter over quarter, while targeting positive operating income by Q3 2026, supported by growing 340B contract activity, improved segment profitability and a solid balance sheet with approximately $11 million in cash and no unsecured debt.


InvestorNewsBreaks – VolitionRx Ltd. (NYSE American: VNRX) Reports Finger-Prick Breakthrough for Nucleosome Detection in Sepsis

April 29, 2026VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company, announced a technical milestone with the successful detection of nucleosomes in capillary blood from critically ill patients with sepsis using a lateral flow finger-prick prototype. The study, conducted as part of the SUMMIT program, demonstrated the feasibility of detecting nucleosomes in capillary samples.